Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer

NCT00810017 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Terminated due to difficulty in accruing patients

Conditions

HER-2 Positive Metastatic Breast Cancer

Interventions

DRUG: Etoposide
DRUG: Trastuzumab

Sponsor

Medstar Health Research Institute

Collaborators

[object Object]